Health

For three months Tahmina Tabassum relearned what she knew about industry and entrepreneurship during a placement with biotech Azafaros BV, a whirlwind experience that included a stint at the company’s headquarters in Basel.

Professor Kris Thurecht and the AIBN team are working to improve the targeting ability of these molecules to unlock the power of radiopharmaceuticals.

Early work has begun at the AIBN on a synthetic, drug-free solution that helps osteoarthritis patients with problem joints.

AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.

AIBN researchers are exploring potential nanoscale processes that explain how the body's text messages move about.

The gold standard test for oesophageal cancer involves a tube being stuck down your throat. PhD scholar Ramlah Khamis is working on a better method that could, in turn, help lift survival rates.

AIBN researchers are using synthetic brain organoid models, grown in a laboratory from human stem cells, to find new ways to rejuvenate brains that have been prematurely aged by COVID-19.

In 2023, a cure for ALS remains elusive, and there are still no treatments to reverse its effects. But AIBN researchers are piecing together information that could get us there.

Four AIBN-led projects have been recognised in latest round of the $220 million Australian Research Council Discovery scheme, a program that recognises research with economic, commercial, environmental, social and/or cultural benefits.

There has been a huge increase in studies on extracellular vesicles, as these biological ‘text messages’ can be harnessed to develop therapeutic and diagnostic approaches for diseases, such as cancer.